CarbGeM Inc. (Headquarters: Shibuya-ku, Tokyo; CEO: Masakazu Nakajima; hereinafter “CarbGeM”) is pleased to announce that our director, Makoto Taketani, presented two research topics at “ASM Microbe 2025,” held from June 19 to 23, 2025, in Los Angeles, USA.
This year, two of our research studies were selected for poster presentation. The first study featured our cloud-based AI image analysis platform CarbConnect®, and the second study focused on the Bacterial Growth Monitor (BGM), a novel technology for real-time, quantitative measurement of microbial growth on solid agar media.
CarbConnect® is a platform that enables secure image storage and real-time communication, supporting imaging applications in both clinical and research environments. As an AI-powered tool, it is designed to reduce human error and improve efficiency in microbiological testing, driving digital transformation (DX) in laboratory operations.
•For more information, visit https://carbgem.com/en/product-en/carbconnect-en/
The Bacterial Growth Monitor (BGM) is a proprietary technology that detects optical changes associated with bacterial growth on agar media with high sensitivity. BGM holds great potential for drug discovery and research applications, including the rapid evaluation of antimicrobial efficacy.
•For more information, visit https://carbgem.com/en/bacteria-growth-monitor-ie-en/
These presentations reflect our commitment to expanding international collaborations and partnerships, particularly in the United States and beyond, as we pursue global commercialization, strategic alliances, and licensing opportunities for our technologies and services.
Presented Abstracts:
• Advancing Microbiology Diagnostics with CarbConnect®: AI-powered Tools for Reliable Results and Research
(Session: POM02 / Date: June 20, 2025)
• Quantitative Monitoring of Microbial Growth on Solid Agar Medium Using a Novel Bacterial Growth Monitor
(Session: AAR06 / Date: June 22, 2025)
About ASM Microbe 2025
Organized by the American Society for Microbiology (ASM), founded in 1899, ASM Microbe is the world’s largest microbiology-focused academic conference. Researchers, educators, clinicians, and professionals from a broad spectrum of microbiological and related scientific fields gather to share the latest research, discuss emerging technologies, and exchange ideas.
The conference covers a wide range of topics—from fundamental microbiology to clinical and industrial applications—and includes poster sessions, symposia, and cutting-edge product exhibitions. It serves as a vital platform for tracking trends and innovations at the forefront of the microbiology field.
For inquiries regarding our presentations, please contact:
press[at]carbgem.com
About CarbGeM Inc.
CarbGeM is a technology company advancing diagnostic support, research efficiency, and quality management in the life sciences through cutting-edge innovations including regulatory-compliant Software as a Medical Device (SaMD). We are committed to addressing social issues such as the shortage of skilled technicians and healthcare disparities by providing fast, accurate, and accessible results that support both clinical and industrial settings.
Leveraging AI and digital platforms, CarbGeM strengthens collaboration among researchers and healthcare professionals, contributing to solutions for global challenges like antimicrobial resistance (AMR).
Our efforts have been recognized with numerous awards, including the Tokyo Social Innovation Tech Award 2024. Through open innovation with top research institutions and industry-academia-government collaboration, we are shaping the future of healthcare and scientific discovery.
• Headquarters: 1-5-13 Jinnan, Shibuya-ku, Tokyo, Japan
• CEO: Masakazu Nakajima
• Website: https://carbgem.com/en/
